Lidocaine Hydrochloride Injection Small Volume Injection Ampoule 0.1%

• Application: Internal Medicine
• Usage Mode: Injection
• Suitable for: Elderly, Adult
• State: Liquid
• Shape: Injection
• Type: Inorganic Chemicals
• Pharmaceutical Technology: Chemical Synthesis
• Drug Reg./Approval No.: H20243411
• Transport Package: 50 Anpoules/Box
• Specification: 5ml/anpoule
• Origin: China
• HS Code: 30049090
• Production Capacity: 1000000pieces/Year

Product Description

Lidocaine Hydrochloride Injection	plastic anpoule	5ml
Lidocaine Hydrochloride Injection	plastic anpoule	10ml

Product Description

Indications:

This product is a local anesthetic and anti-arrhythmic drug. It is mainly used for infiltration anesthesia, epidural anesthesia, topical anesthesia (including mucosal anesthesia during thoracoscopy or abdominal surgery) and nerve block. This product can also be used for ventricular premature contractions and ventricular tachycardia after acute myocardial infarction, and can also be used for digitalis poisoning, cardiac surgery and ventricular arrhythmia caused by cardiac catheterization. This product is usually ineffective for supraventricular arrhythmias.

Dosage

Commonly used for anesthesia in adults:
1. Topical anesthesia: 2%~4% solution should not exceed 100mg at a time. The dose of injection should not exceed 4.5 mg/kg (without epinephrine) or every 7 mg/kg (with a concentration of 1:200000 epinephrine);
2 Sacral block for labor analgesia: with 1.0% solution, limited to 200 mg;
3. Epidural block: 1.5%~2.0% solution for thoracolumbar segment, 250~300mg;
4. Infiltration anesthesia or intravenous regional block: with 0.25%~0.5% solution, 50~300mg;
5. Peripheral nerve block: brachial plexus (unilateral) with 1.5% solution, 20~300mg, dental with 2% solution, 20~100mg, intercostal nerve (each branch) with 1% solution.

Detailed Photos

Company Profile

Shijiazhuang No. 4 Pharmaceutical Co., Ltd., as one of the leading manufacturers in Chinese pharmaceutical industry and a well-known brand, has a business history of seventy years. The company principally specializes in R & D, manufacture and sales of wide types of drugs mainly including intravenous infusion.
The production lines have achieved full automation control and information control in the production process and logistics process and reached international advanced level by integrating the world's leading equipment and technology.
With product quality as its life, the Company always organizes production in strict accordance with GMP requirements, establishes and implements superior service concepts and measures and provides guarantee for the health of the majority of patients at home and abroad with excellent quality products and services.
The Company has a powerful R&D team and made a number of achievements in scientific research and undertaken many major scientific and technological innovation projects and industrialization projects by firmly grasping the pulse of pharmaceutical development, increasing new product development investment and accelerating the pace of technological innovation.
Large volume injection is the key products, tablets, capsules, small volume injection and other forms are manufactured also. Recently API has been put into production and sales. There are more than ten international advanced production lines for the large volume injection, its production scale, technology level, brand influence and economic benefit are on the forefront of domestic counterparts, and it has become one of China's top 100 pharmaceutical industry enterprises and China's top 10 chemical and pharmaceutical industry preparation export-oriented excellent enterprise brands for many consecutive years.
The products are radiated to all provinces, autonomous regions and municipalities in China and also exported to many overseas markets, including more than 80 countries in Asia, Americas, Europe, Oceania, Africa and other continents, and it has become one of the main export enterprises of infusion products.